TRAIL stops graft-vs-host disease after stem cell transplant for leukemia Oncology Nurse Advisor TRAIL stops graft-vs-host disease after stem cell transplant for leukemia. Immune cells engineered to express a higher level of a protein known as TRAIL destroyed cells that cause graft-versus-host disease (GVHD) in persons with leukemia and other ... |
